BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 25427905)

  • 1. TLR4-dependent tumor-initiating stem cell-like cells (TICs) in alcohol-associated hepatocellular carcinogenesis.
    Machida K; Feldman DE; Tsukamoto H
    Adv Exp Med Biol; 2015; 815():131-44. PubMed ID: 25427905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NANOG-Dependent Metabolic Reprogramming and Symmetric Division in Tumor-Initiating Stem-like Cells.
    Machida K
    Adv Exp Med Biol; 2018; 1032():105-113. PubMed ID: 30362094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reciprocal regulation by TLR4 and TGF-β in tumor-initiating stem-like cells.
    Chen CL; Tsukamoto H; Liu JC; Kashiwabara C; Feldman D; Sher L; Dooley S; French SW; Mishra L; Petrovic L; Jeong JH; Machida K
    J Clin Invest; 2013 Jul; 123(7):2832-49. PubMed ID: 23921128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alcohol, TLR4-TGF-β antagonism, and liver cancer.
    Tsukamoto H; Mishra L; Machida K
    Hepatol Int; 2014 Sep; 8 Suppl 2(Suppl 2):408-12. PubMed ID: 26201318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TLR4 Signaling via NANOG Cooperates With STAT3 to Activate Twist1 and Promote Formation of Tumor-Initiating Stem-Like Cells in Livers of Mice.
    Uthaya Kumar DB; Chen CL; Liu JC; Feldman DE; Sher LS; French S; DiNorcia J; French SW; Naini BV; Junrungsee S; Agopian VG; Zarrinpar A; Machida K
    Gastroenterology; 2016 Mar; 150(3):707-19. PubMed ID: 26582088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 destabilizing protein skews asymmetric division and enhances NOTCH activation to direct self-renewal of TICs.
    Choi HY; Siddique HR; Zheng M; Kou Y; Yeh DW; Machida T; Chen CL; Uthaya Kumar DB; Punj V; Winer P; Pita A; Sher L; Tahara SM; Ray RB; Liang C; Chen L; Tsukamoto H; Machida K
    Nat Commun; 2020 Jun; 11(1):3084. PubMed ID: 32555153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer stem cells generated by alcohol, diabetes, and hepatitis C virus.
    Machida K; Chen CL; Liu JC; Kashiwabara C; Feldman D; French SW; Sher L; Hyeongnam JJ; Tsukamoto H
    J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2(Suppl 2):19-22. PubMed ID: 22320911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NANOG Metabolically Reprograms Tumor-Initiating Stem-like Cells through Tumorigenic Changes in Oxidative Phosphorylation and Fatty Acid Metabolism.
    Chen CL; Uthaya Kumar DB; Punj V; Xu J; Sher L; Tahara SM; Hess S; Machida K
    Cell Metab; 2016 Jan; 23(1):206-19. PubMed ID: 26724859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell fate, metabolic reprogramming and lncRNA of tumor-initiating stem-like cells induced by alcohol.
    Machida K
    Chem Biol Interact; 2020 May; 323():109055. PubMed ID: 32171851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NUMB phosphorylation destabilizes p53 and promotes self-renewal of tumor-initiating cells by a NANOG-dependent mechanism in liver cancer.
    Siddique HR; Feldman DE; Chen CL; Punj V; Tokumitsu H; Machida K
    Hepatology; 2015 Nov; 62(5):1466-79. PubMed ID: 26174965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-like receptor 4 mediates synergism between alcohol and HCV in hepatic oncogenesis involving stem cell marker Nanog.
    Machida K; Tsukamoto H; Mkrtchyan H; Duan L; Dynnyk A; Liu HM; Asahina K; Govindarajan S; Ray R; Ou JH; Seki E; Deshaies R; Miyake K; Lai MM
    Proc Natl Acad Sci U S A; 2009 Feb; 106(5):1548-53. PubMed ID: 19171902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic signaling pathways and origins of tumor-initiating stem-like cells of hepatocellular carcinomas induced by hepatitis C virus, alcohol and/or obesity.
    Chen CL; Tsukamoto H; Machida K
    Hepatol Int; 2014 Jul; 8(3):330-8. PubMed ID: 26202636
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma.
    Liu WT; Jing YY; Yu GF; Han ZP; Yu DD; Fan QM; Ye F; Li R; Gao L; Zhao QD; Wu MC; Wei LX
    Cancer Lett; 2015 Mar; 358(2):136-143. PubMed ID: 25511737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD133(+) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling.
    Tang KH; Ma S; Lee TK; Chan YP; Kwan PS; Tong CM; Ng IO; Man K; To KF; Lai PB; Lo CM; Guan XY; Chan KW
    Hepatology; 2012 Mar; 55(3):807-20. PubMed ID: 21994122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NOTCH localizes to mitochondria through the TBC1D15-FIS1 interaction and is stabilized via blockade of E3 ligase and CDK8 recruitment to reprogram tumor-initiating cells.
    Choi HY; Zhu Y; Zhao X; Mehta S; Hernandez JC; Lee JJ; Kou Y; Machida R; Giacca M; Del Sal G; Ray R; Eoh H; Tahara SM; Chen L; Tsukamoto H; Machida K
    Exp Mol Med; 2024 Feb; 56(2):461-477. PubMed ID: 38409448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Existence of cancer stem cells in hepatocellular carcinoma: myth or reality?
    Machida K
    Hepatol Int; 2017 Mar; 11(2):143-147. PubMed ID: 27990610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncHOXA10 drives liver TICs self-renewal and tumorigenesis via HOXA10 transcription activation.
    Shao M; Yang Q; Zhu W; Jin H; Wang J; Song J; Kong Y; Lv X
    Mol Cancer; 2018 Dec; 17(1):173. PubMed ID: 30545354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-initiating stem-like cells and drug resistance: carcinogenesis through Toll-like receptors, environmental factors, and virus.
    Machida K
    Drug Deliv Transl Res; 2013 Apr; 3(2):152-64. PubMed ID: 25787983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The TBC1D15 oncoprotein controls stem cell self-renewal through destabilization of the Numb-p53 complex.
    Feldman DE; Chen C; Punj V; Machida K
    PLoS One; 2013; 8(2):e57312. PubMed ID: 23468968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CXCL11 promotes self-renewal and tumorigenicity of α2δ1
    Zhang Y; Zhao W; Li S; Lv M; Yang X; Li M; Zhang Z
    Cancer Lett; 2019 May; 449():163-171. PubMed ID: 30771435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.